Literature DB >> 12114722

Immunocytochemical Investigations on the Vascularization of Pituitary Adenomas.

Marek Pawlikowski1, Hanna Pisarek, Maria Jaranowska.   

Abstract

Blood vessels within pituitary adenomas were visualized using the immunocytochemical reaction for Factor VIII (von Willebrand Factor), a specific marker of the vascular endothelium. The number of immunopositive vascular profiles were counted and expressed as a mean number per one microscopic field. The results were related to the type of adenoma, established on the basis of immunocytochemical investigation using the antibodies against pituitary hormones or a-subunit (a-SU). It was found that the richest vascularization occurred in adenomas expressing follicle-stimulating hormone (FSH). The possible role of FSH in pituitary angiogenesis is discussed.

Entities:  

Year:  1997        PMID: 12114722     DOI: 10.1007/bf02738785

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  10 in total

1.  Relation of neovascularisation to metastasis of non-small-cell lung cancer.

Authors:  P Macchiarini; G Fontanini; M J Hardin; F Squartini; C A Angeletti
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

Review 2.  Diagnostic and therapeutic applications of angiogenesis research.

Authors:  J Folkman
Journal:  C R Acad Sci III       Date:  1993-09

3.  Pituitary glycoprotein hormones and interleukins secretion. In vitro and in vivo human study.

Authors:  J Komorowski; M Pawlikowski; H Stepień
Journal:  Ann N Y Acad Sci       Date:  1995-07-21       Impact factor: 5.691

4.  Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.

Authors:  H Stepień; M Grochal; K W Zieliński; S Mucha; J Kunert-Radek; A Kulig; A Stawowy; H Pisarek
Journal:  J Endocrinol       Date:  1996-07       Impact factor: 4.286

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Production of interleukin-6 by anterior pituitary cells in vitro.

Authors:  B L Spangelo; R M MacLeod; P C Isakson
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

7.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

8.  Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study.

Authors:  Martin Jugenburg; Kalman Kovacs; Lucia Stefaneanu; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

9.  Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression.

Authors:  G A Dissen; H E Lara; W H Fahrenbach; M E Costa; S R Ojeda
Journal:  Endocrinology       Date:  1994-03       Impact factor: 4.736

Review 10.  Angiogenesis in breast carcinoma--clinicopathologic relevance and potential use as a quantifiable surrogate endpoint biomarker.

Authors:  D W Visscher; W D Lawrence; S Boman
Journal:  J Cell Biochem Suppl       Date:  1994
  10 in total
  9 in total

1.  Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas.

Authors:  Anna Gruszka; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Paolo Gaetani; Umberto Goglia; Manfred Tschabitscher; Pietro Mortini; Riccardo Rodriguez y Baena
Journal:  Neurosurg Rev       Date:  2008-03-08       Impact factor: 3.042

3.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

4.  Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.

Authors:  Daizo Yoshida; Kyongsong Kim; Michio Yamazaki; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

5.  Microvessel density and area in pituitary microadenomas.

Authors:  Ewa Jasek; Alicja Furgal-Borzych; Grzegorz J Lis; Jan A Litwin; Ewa Rzepecka-Wozniak; Franciszek Trela
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

6.  Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Giorgia Ceva-Grimaldi; Carlo Russo; Paolo Gaetani; Enrico Aimar; Daniel Levi; Patrizia Pisano; Flavio Tancioni; Giancarlo Nicola; Manfred Tschabitscher; Nicola Dioguardi; Riccardo Rodriguez Y Baena
Journal:  J Anat       Date:  2007-09-03       Impact factor: 2.610

7.  Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas.

Authors:  Koji Takada; Shozo Yamada; Akira Teramoto
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 8.  Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.

Authors:  Carolina Cristina; Guillermina María Luque; Gianina Demarchi; Felicitas Lopez Vicchi; Lautaro Zubeldia-Brenner; Maria Ines Perez Millan; Sofia Perrone; Ana Maria Ornstein; Isabel M Lacau-Mengido; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Int J Endocrinol       Date:  2014-11-18       Impact factor: 3.257

9.  Angiogenesis in Endocrine Neoplasms.

Authors:  Martin Jugenburg; Kalman Kovacs; Ivan Jugenburg; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.